Skip to content

GORE-TEX Stretch Vascular Graft-Bifurcated SBT1602DRecalls & reported problems

W. L. Gore & Associates, Inc. · STRETCH VASC GRAFT TW BIFUR 16-8mmX50cm · Class 2 · Implant

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00733132612024), received between Dec 17, 2020 and Dec 17, 2020 — classified as 1 injury.

The most frequently reported specific device problem is “Contamination” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Contamination1

Patient problems

  • Bacterial Infection1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • InjuryDec 17, 2020Contamination; Contamination

    IT WAS REPORTED TO GORE THAT PATIENT UNDERWENT ENDOVASCULAR TREATMENT FOR A RUPTURED ANEURYSM OF THE ABDOMINAL AORTA WITH A GORE-TEX® STRETCH VASCULAR GRAFT - THIN-WALLED BIFURCATED. IT WAS STATED THAT THE PROSTHESIS WAS IMPLANTED ON (B)(6) 2020 AS AN AORTO-BI-ILIAC BYPASS. REPORTEDLY, ON (B)(6) 2020, AFTER ABOUT 2 MONTHS AND 7 DAYS, THE PROSTHESIS WAS EXPLANTED DUE TO INFECTION TO METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS AND ENTEROCOCCUS FAECALIS.

    Patient problems: Bacterial Infection

    MAUDE report 11027116 ↗

Other PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices

All PROSTHESIS, VASCULAR GRAFT, OF 6MM AND GREATER DIAMETER devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page